GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 634 filers reported holding GLAXOSMITHKLINE PLC in Q2 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $779,000 | -86.2% | 18,217 | -85.2% | 0.01% | -86.4% |
Q3 2014 | $5,646,000 | -10.7% | 122,820 | +3.9% | 0.04% | -10.2% |
Q2 2014 | $6,324,000 | -29.5% | 118,249 | -29.6% | 0.05% | -32.9% |
Q1 2014 | $8,972,000 | -9.3% | 167,929 | -9.3% | 0.07% | -7.6% |
Q4 2013 | $9,888,000 | +4.1% | 185,201 | -2.2% | 0.08% | -2.5% |
Q3 2013 | $9,500,000 | +26.6% | 189,362 | +26.1% | 0.08% | +24.6% |
Q2 2013 | $7,501,000 | – | 150,112 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |